Dave Schulte will take over as managing director of McKesson Ventures, the corporate venturing arm of US-based healthcare product and IT technology supplier McKesson Corporation, next month, the company revealed yesterday.
Schulte will join McKesson from managed care consortium Kaiser Permanente, where he served as vice president and managing director of its strategic investment unit, Kaiser Permanente Ventures, for 12 years.
McKesson Ventures was launched in December 2014 to invest in companies looking to disrupt the healthcare industry. It has so far funded telemedicine company Carena, healthcare marketplace Accolade, telepharmacy platform PipelineRx and a seed fund raised by healthcare venture capital fund Rock Health.
Schute will co-lead the development and management of the unit alongside its senior vice president and managing director, Tom Rodgers.
Rodgers said: “Dave is a well-respected, active investor in the areas of healthcare where we are focused and adding him to the team will help us continue to grow the fund and develop our portfolio.
“At Kaiser Permanente, he demonstrated how a strategic investor can optimise its partnership with early stage companies to build value for both sides.”
Schulte joined Kaiser Permanente Ventures in 2003 from investment bank and asset management firm Piper Jaffray, where he was an associate. He had previously been an associate at Hambrecht & Quist and UBS.
– Photo courtesy of LinkedIn